CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP announced it is investigating claims on behalf of Cellebrite DI (NASDAQ: CLBT) investors for potential securities-law violations. The probe references Cellebrite's August 13, 2026 Q2 report, in which ARR missed the bottom of prior guidance, full-year ARR guidance was lowered, and CEO Tom Hogan was abruptly replaced; shares fell 29% that day.
Key figures
- Arr vs guidance
- missed bottom end of prior guidance
- Guidance action
- full-year ARR guidance lowered
- Prior news date
- 2026-08-13
- Share price drop pct
- 29%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.